Table of Contents
SANTA MONICA, Calif. — GoodRx has announced the appointment of Aaron Crittenden as president of Rx Marketplace and Scott Pope as chief pharmacy officer and head of Clinical Engagement, effective immediately.
Crittenden will be responsible for the management and financial performance of GoodRx’s Rx Marketplace offering, working with key retail pharmacy, pharmacy benefit manager (PBM), employer, and manufacturer partners. He will also play a major role in shaping GoodRx’s long-term growth strategy and serve as a strategic advisor to the CEO and president, helping to guide the company’s broader vision and business priorities.
Since joining GoodRx in 2020, Crittenden has played a pivotal role in building and scaling the business across multiple leadership positions. As head of Manufacturer Solutions and then Chief Revenue Officer, he helped launch the company’s Pharma Manufacturer Solutions offering and played a key role in growing revenue to $100M+ in just a few years. Prior to GoodRx, he founded ReMy Health, where he developed automation solutions for affordability programs and specialty medication access, and contributed to developing the infrastructure behind the PillPack data network. Earlier in his career, he held leadership roles at Allscripts, where he was responsible for oversight of electronic prescribing, pharma and pharmacy benefits manager (PBM) innovation, and its patient portal business.
Pope will be responsible for all aspects of GoodRx’s relationships with physicians, pharmacists, nurses, and all healthcare professionals, including marketing and product development. This includes pharmacy strategy, clinical engagement, and industry partnerships.
By joining GoodRx, Pope will continue his nearly 30 years of successful service in the U.S. health care system. His diverse experience ranges from providing direct patient care to executive level leadership, growing revenue streams, enhancing patient care, scaling infrastructure, and forging industry partnerships for companies including Premier, Inc., Hitachi, In Scope Ventures, and more.
“Our path forward is laser-focused on improving the prescription experience for all stakeholders, from the retail pharmacies looking to innovate and drive profitability to the healthcare professionals seeking affordable medication solutions for their patients so they can adhere to their treatment plans,” said Wendy Barnes, chief executive officer and president of GoodRx. “I’m confident Aaron and Scott are the right leaders to help us deliver against these key business priorities and accelerate our efforts to fill gaps in insurance coverage and reduce friction across the healthcare system.”
